missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CEP55 Polyclonal Antibody

Description
Recommended positive controls: IMR32, U87-MG, MCF-7, HeLa. Predicted reactivity: Rat (80%), Bovine (87%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Plays a role in mitotic exit and cytokinesis (PubMed:16198290, PubMed:17853893). Recruits PDCD6IP and TSG101 to midbody during cytokinesis. Required for successful completion of cytokinesis (PubMed:17853893). Not required for microtubule nucleation (PubMed:16198290). Plays a role in the development of the brain and kidney (PubMed:28264986). [UniProt].
Specifications
Specifications
| Antigen | CEP55 |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.85 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7 |
| Gene | CEP55 |
| Gene Accession No. | Q53EZ4 |
| Gene Alias | 1200008O12Rik; 2700032M20Rik; C10orf3; cancer/testis antigen 111; centrosomal protein 55; centrosomal protein 55kDa; centrosomal protein of 55 kDa; centrosomal protein of 55 kDa; LOW QUALITY PROTEIN: centrosomal protein of 55 kDa; centrosomal protein of 55 kDa-like protein; CEP55; CT111; RGD1305340; Up-regulated in colon cancer 6; URCC6 |
| Gene Symbols | CEP55 |
| Show More |